Antioxidant Barrier and Oxidative Damage to Proteins, Lipids, and DNA/RNA in Adrenal Tumor Patients

Figure 6

Plasma and urine DNA/RNA oxidation products (a, b) and plasma/urine index of DNA/RNA oxidation product content (c) of the controls, incidentaloma, pheochromocytoma, and Cushing’s/Conn’s adenoma patients. Results are presented as median with minimum and maximum. and indicate significant differences from the controls; ^^ and ^^^ indicate significant differences from the pheochromocytoma group.

(a)

(b)

(c)